Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: The Role of Food Sensitivity in Psoriasis [NA]
A clinical trial update from the University of Michigan investigates whether food sensitivity affects psoriasis; the study status is complet…
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: Evaluation of Vitamin D Levels in Psoriasis Patients
A clinical trial evaluating vitamin D levels in psoriasis patients has been withdrawn.
-
CLINICAL_TRIALS other · 2024-05-07Clinical Trial Update: Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control [EARLY_Phase 1]
Early Phase 1 trial snapshot for comprehensive intervention targeting diabetes mellitus and psoriasis comorbidity; the study is not yet recr…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy [Phase 4]
A Phase 4 head-to-head clinical trial comparing subcutaneous risankizumab to oral apremilast in adults with moderate plaque psoriasis; the t…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis [NA]
A completed clinical trial evaluating an electrolyzed water spray for mild senile groin eczema, neurodermatitis, and psoriasis; results are …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Study to Assess the Efficacy and Safety of Orismilast in Psoriasis [Phase 2]
Phase 2 trial assessing the efficacy and safety of orismilast in psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis [Phase 4]
Phase 4 trial evaluating add-on Enstilar in patients using Otezla for psoriasis has completed with posted results.
-
FDA approval · 2024-04-10FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Aurobindo Pharma Limited)
FDA approved Betamethasone dipropionate topical from Aurobindo Pharma Limited under an original ANDA for inflammatory and pruritic corticost…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray [Phase 4]
Phase 4 clinical trial update for Topicort Topical Spray in psoriasis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases [Phase 4]
Phase 4 clinical trial update evaluating intradermal Tozinameran (COVID-19 vaccine) in patients with immune-mediated dermatologic diseases.
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants [Phase 1]
A Phase 1 clinical trial evaluating the safety and potential benefit of GSK2982772 in moderate to severe psoriasis has completed with result…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis [Phase 3]
Phase 3 trial results (efficacy and safety) for brodalumab in adolescents aged 12 to 17 with moderate-to-severe plaque psoriasis; the study …
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors [Phase 2]
Phase 2 proof-of-activity study of Orticumab in subjects with psoriasis and cardiometabolic risk factors completed.
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Study of Mirikizumab in Participants With Plaque Psoriasis [Phase 1]
A Phase 1 clinical trial of mirikizumab in participants with plaque psoriasis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating IBI112 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing subcutaneous DMB-3115 to Stelara in moderate to severe chronic plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial updates for Hemay005 in moderate to severe plaque psoriasis have been completed.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update on the interchangeability of ABP 654 for moderate to severe plaque psoriasis has completed with results posted.
-
FDA approval · 2024-01-08FDA Approved: METHOXSALEN — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for methoxsalen submitted by Strides Pharma Science Limited. This action updates the approved la…
-
FDA approval · 2023-12-28FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis [NA]
Pilot study assessing the effect of nicotinamide riboside on immune activation in psoriasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: A Study of QY101 Ointment in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update for QY101 ointment in subjects with psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis completed with results posted in 2023.
-
FDA approval · 2023-12-14FDA Approved: CYCLOSPORINE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals' generic cyclosporine under an original application (ANDA 203880), expanding access to this immunosuppress…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects [Phase 3]
Phase 3 bioequivalence study of two Apremilast 30 mg tablet products completed in healthy adults.